Review on the pharmacological mechanisms and novel drug delivery system of vitexin

Abstract

Vitexin is a natural phytoflavonoid glycoside extracted from the leaves of vitexin, a plant of the Verbenaceae family, which is an active ingredient in many traditional Chinese medicines and is present in a wide range of medicinal plants. In this review, pharmacological effects including anti-inflammatory, diabetes mellitus are described. The novel formulation of vitexin of nano delivery and hybrid micelles are elucidated.

Keywords

vitexin / pharmacological effect / bioavailability

References

[1] Gu CB, Cai M, Yuan XH, et al. Research progress on plant resources distribution of vitexin and its pharmacological effects[J]. China Journal of Chinese Materia Medica, 2015, 40 (3): 382-389.

[2] Guo L, Shi L. Vitex in improves cerebral is chemiareperfusion injury by attenuating oxidative injury and ferroptosis via Keap1/Nrf2/HO-1signaling[J]. Neurochem Res, 2023, 48 (3): 980-995.

[3] Liu Y, Zhu S, Liu J, et al. Vitexin regulates angiogenesis and osteogenesis in ovariectomy-induced osteoporosis of rats via the VDR/PI3K/AKT/eNOS signaling pathway[J]. J Agric Food Chem, 2023, 71 (1): 546-556.

[4] Zhang D, Ning T, Wang H. Vitexin alleviates inflammation and enhances apoptosis through the regulation of the JAK/ STAT/SOCS signaling pathway in the arthritis rat model[J]. J Biochem Mol Toxicol, 2022, 36 (12): e23201.

[5] Tao M, Li R, Zhang Z, et al. Vitexin and isovitexin act through inhibition of insulin receptor to promote longevity and fitness in caenorhabditis elegans[J]. Mol Nutr Food Res, 2022, 66 (17): e2100845.

[6] Peng Y, Gan R, Li H, et al. Absorption, metabolism, and bioactivity of vitexin: Recent advances in understanding the efficacy of an important nutraceutical[J]. Crit Rev Food Sci Nutr, 2021, 61 (6): 1049-1064.

[7] He M, Min JW, Kong WL, et al. A review on the pharmacological effects of vitexin and isovitexin[J]. Fitoterapia, 2016, 115: 74-85.

[8] Xu T, Fan Z, Lou J, et al. Enzymatic synthesis of vitexin glycosides and their activity[J]. RSC Adv, 2022, 12 (37): 23839-23844.

[9] Rocha B, de Morais LA, Viana MC, et al. Promising strategies for improving oral bioavailability of poor water- soluble drugs[J]. Expert Opin Drug Discov, 2023, 18 (6): 615-627.

[10] Zhao J, Yang J, Xie Y. Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview[J]. Int J Pharm, 2019, 570: 118642.

[11] Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review[J]. Gastroenterology, 2012, 142 (1): 46-54.

[12] Ungaro R, Mehandru S, Allen PB, et al. Ulcerative colitis[J]. Lancet, 2017, 389 (10080): 1756-1770.

[13] Chen Y, Wang B, Yuan X, et al. Vitexin prevents colitis- associated carcinogenesis in mice through regulating macrophage polarization[J]. Phytomedicine, 2021, 83: 153489.

[14] Ni J, Wu GD, Albenberg L, et al. Gut microbiota and IBD: Causation or correlation?[J]. Nat Rev Gastroenterol Hepatol, 2017, 14 (10): 573-584.

[15] Nishida A, Inoue R, Inatomi O, et al. Gut microbiota in the pathogenesis of inflammatory bowel disease[J]. Clin J Gastroenterol, 2018, 11 (1): 1-10.

[16] Nishino K, Nishida A, Inoue R, et al. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease[J]. J Gastroenterol, 2018, 53 (1): 95-106.

[17] Li S, Luo L, Wang S, et al. Regulation of gut microbiota and alleviation of DSS-induced colitis by vitexin[J]. Eur J Nutr, 2023, 62 (8): 3433-3445.

[18] Zhang J, Liang F, Chen Z, et al. Vitexin protects against dextran sodium sulfate-induced colitis in mice and its potential mechanisms[J]. J Agric Food Chem, 2022, 70 (38): 12041-12054.

[19] Rogler G. Chronic ulcerative colitis and colorectal cancer[J]. Cancer Lett, 2014, 345 (2): 235-241.

[20] Sun M, Liu Y, Song Y, et al. The ameliorative effect of Lactobacillus plantarum-12 on DSS-induced murine colitis[J]. Food Funct, 2020, 11 (6): 5205-5222.

[21] Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis[J]. Immunity, 2017, 46 (2): 183-196.

[22] Weyand CM, Fujii H, Shao L, et al. Rejuvenating the immune system in rheumatoid arthritis[J]. Nat Rev Rheumatol, 2009, 5 (10): 583-588.

[23] Tran CN, Lundy SK, Fox DA. Synovial biology and T cells in rheumatoid arthritis[J]. Pathophysiology, 2005, 12 (3): 183-189.

[24] Rosillo MA, Alarcón-de-la-Lastra C, Sánchez-Hidalgo M. An update on dietary phenolic compounds in the prevention and management of rheumatoid arthritis[J]. Food Funct, 2016, 7 (7): 2943-2969.

[25] Chen Z, Bozec A, Ramming A, et al. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis[J]. Nat Rev Rheumatol, 2019, 15 (1): 9-17.

[26] Albanesi C, Scarponi C, Cavani A, et al. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes[J]. J Invest Dermatol, 2000, 115 (1): 81-87.

[27] Shouda T, Yoshida T, Hanada T, et al. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis[J]. J Clin Invest, 2001, 108 (12): 1781-1788.

[28] Angier RB, Boothe JH, Hutchings BL, et al. The structure and synthesis of the liver L. casei factor[J]. Science, 1946, 103 (2683): 667-669.

[29] Gubner R, August S, Ginsberg V. Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis[J]. Am J Med Sci, 1951, 221 (2): 176-182.

[30] Lalithakumari K, Krishnaraju AV, Sengupta K, et al. Safety and toxicological evaluation of a novel, standardized 3-O-acetyl-11-keto-beta-Boswellic acid (AKBA)-enriched boswellia serrata extract (5-Loxin(R))[J]. Toxicol Mech Methods, 2006, 16 (4): 199-226.

[31] Salvemini D, Wang ZQ, Wyatt PS, et al. Nitric oxide: A key mediator in the early and late phase of carrageenan-induced rat paw inflammation[J]. Br J Pharmacol, 1996, 118 (4): 829-838.

[32] Huang KW, Hsu FF, Qiu JT, et al. Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer[J]. Sci Adv, 2020, 6 (3): eaax5032.

[33] Zhou Z, Sun B, Yu D, et al. Gut microbiota: An important player in type 2 diabetes mellitus[J]. Front Cell Infect Microbiol, 2022, 12: 834485.

[34] Galgano L, Guidetti GF, Torti M, et al. The controversial role of LPS in platelet activation in vitro[J]. Int J Mol Sci, 2022, 23 (18): 10900.

[35] Chen R, Kang R, Tang D. The mechanism of HMGB1 secretion and release[J]. Exp Mol Med, 2022, 54 (2): 91-102.

[36] Cai K, Qi D, Hou X, et al. MCP-1 upregulates amylin expression in murine pancreatic β cells through ERK/JNK- AP1 and NF-κB related signaling pathways independent of CCR2[J]. PLoS One, 2011, 6 (5): e19559.

[37] Wang F, Yin J, Ma Y, et al. Vitexin alleviates lipopolysaccharideinduced islet cell injury by inhibiting HMGB1 release[J]. Mol Med Rep, 2017, 15 (3): 1079-1086.

[38] Inamdar S, Joshi A, Malik S, et al. Vitexin alleviates non- alcoholic fatty liver disease by activating AMPK in high fat diet fed mice[J]. Biochem Biophys Res Commun, 2019, 519 (1): 106-112.

[39] Yan Y, Jiang W, Tan Y, et al. hucMSC exosome-derived GPX1 is required for the recovery of hepatic oxidant injury[J]. Mol Ther, 2017, 25 (2): 465-479.

[40] Abdulai IL, Kwofie SK, Gbewonyo WS, et al. Multitargeted effects of vitexin and isovitexin on diabetes mellitus and its complications[J]. Scientific World Journal, 2021, 2021: 6641128.

[41] Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: Clinical insights and vascular mechanisms[J]. Can J Cardiol, 2018, 34 (5): 575-584.

[42] Papadopoulou-Marketou N, Paschou SA, Marketos N, et al. Diabetic nephropathy in type 1 diabetes[J]. Minerva Med, 2018, 109 (3): 218-228.

[43] Zhang S, Zhang S, Wang H, et al. Vitexin ameliorated diabetic nephropathy via suppressing GPX4-mediated ferroptosis[J]. Eur J Pharmacol, 2023, 951: 175787.

[44] Choo CY, Sulong NY, Man F, et al. Vitexin and isovitexin from the leaves of ficus deltoidea with in-vivo α-glucosidase inhibition[J]. J Ethnopharmacol, 2012, 142 (3): 776-781.

[45] Nurdiana S, Goh YM, Ahmad H, et al. Changes in pancreatic histology, insulin secretion and oxidative status in diabetic rats following treatment with ficus deltoidea and vitexin[J]. BMC Complement Altern Med, 2017, 17 (1): 290.

[46] Kuang J, Chen L, Tang Q, et al. The role of sirt6 in obesity and diabetes[J]. Front Physiol, 2018, 9: 135.

[47] Ravichandran S, Singh N, Donnelly D, et al. Pharmacophore model of the quercetin binding site of the SIRT6 protein[J]. J Mol Graph Model, 2014, 49: 38-46.

[48] Singh N, Ravichandran S, Norton DD, et al. Synthesis and characterization of a SIRT6 open tubular column: Predicting deacetylation activity using frontal chromatography[J]. Anal Biochem, 2013, 436 (2): 78-83.

[49] Singh N, Ravichandran S, Spelman K, et al. The identification of a novel SIRT6 modulator from Trigonella foenum-graecum using ligand fishing with protein coated magnetic beads[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2014, 968: 105-111.

[50] Rahim A, Takahashi Y, Yamaki K. Mode of pancreatic lipase inhibition activity in vitro by some flavonoids and non-flavonoid polyphenols[J]. Food Res Int, 2015, 75: 289-294.

[51] Bhalani DV, Nutan B, Kumar A, et al. Bioavailability enhancement techniques for poorly aqueous soluble drugs and therapeutics[J]. Biomedicines, 2022, 10 (9): 2055.

[52] Peanparkdee M, Yooying R. Enhancement of solubility, thermal stability and bioaccessibility of vitexin using phosphatidylcholine-based phytosome[J]. NFS Journal, 2023, 31: 28-38.

[53] Li S, Lv H, Chen Y, et al. N-trimethyl chitosan coated targeting nanoparticles improve the oral bioavailability and antioxidant activity of vitexin[J]. Carbohydr Polym, 2022, 286: 119273.

[54] Yoksan R, Towongphaichayonte P. Vitexin-loaded poly (ethylene glycol) methyl ether-grafted chitosan/alginate nanoparticles: Preparation, physicochemical properties and in vitro release behaviors[J]. J Sci Food Agric, 2024, 104 (2): 956-966.

[55] Zhang J, Li X, Xia X, et al. Vitexin loaded mixed polymeric micelles: Preparation, optimization, evaluation and anti-osteoporotic effect[J]. Biomed Mater, 2023, 18 (4): 37116506.